Commentary · 21 Feb 2026
Conference abstractPublished 3 Oct 2016
Mesh versus acellular dermal matrix in immediate implant-based breast reconstruction: A prospective randomized trial
Medical University of Vienna, Austria
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Comparative studies on the use of meshes and acellular dermal matrices (ADM) in implant-based breast reconstruction (IBBR) have not yet been performed. Methods: This prospective, randomized, controlled, multicenter pilot study was performed at four Austrian breast cancer centers. 50 patients with oncologic or prophylactic indication for mastectomy and IBBR were randomized to immediate IBBR with either an ADM (ProtexaÃ?®) or a titanized mesh (TiLOOPÃ?® Bra). Complications, failed reconstruction, cosmetic outcome, patientsâÂ?Â? quality of life and the thickness of the overlying tissue were recorded immediately postoperatively and three and six months after surgery. Results: 48 patients participated in the study (ProtexaÃ?® group: 23; TiLOOPÃ?® Bra group: 25 patients). The overall complication rate was 31.25% with similar rates in both groups (ProtexaÃ?® group nine vs. TiLOOPÃ?® Bra group six; p=0.188). There was a higher incidence of severe complications leading to failed reconstructions with implant loss in the ProtexaÃ?® group than in the TiLOOPÃ?® Bra group (seven vs. two; p<0.0001). An inverted T-incision technique led to significantly more complications and reconstructive failure with ProtexaÃ?® (p=0.037, p=0.012, respectively). There were no significant differences in patientsâÂ?Â? satisfaction with cosmetic results (p=0.632), but surgeons and external specialists graded significantly better outcomes with TiLOOPÃ?® Bra (p=0.034, p=0.032). Conclusion: This pilot study showed use of TiLOOPÃ?® Bra or ProtexaÃ?® in IBBR and was feasible leading to good cosmetic outcomes and high patient satisfaction. To validate the higher failure rates in the ProtexaÃ?® group, data from a larger trial were required.
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Cancer Science & Therapy.
Perspective · 21 Feb 2026
Finding Potential Passerini Adducts for Anticancer Drug Development
Perspective · 21 Feb 2026
Head and Neck Cutaneous Squamous Cell Carcinoma with Perineural Invasion
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalCancer Science & Therapy
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Daphne Gschwantler-Kaulich”
